Pooled analysis of phase 3 studies of ADS-5102 for levodopa-induced dyskinesia: A detailed review of MDS-UPDRS, part IV (motor complications). (January 2018) - Tanner, C.; Pahwa, R.; Elmer, L.; Isaacson, S.; Johnson, R.; Felt, L.; Patni, R.